As part of a multi-year "Next 100" strategy, Nikon will spend US$2 billion over the next three years to acquire healthcare-related companies and will allocate another US$2 billion in R&D expenses, about a quarter of which will also be set aside for healthcare research.
Nikon currently has around US$2.2 billion in cash and US$1.2 billion in debt.
Nikon expects camera sales to plunge 8% this year and does not expect sales to recover above current levels until FY2016. Total growth over the next three years is expected to be an anemic 2%.
Nikon' strategy for the Imaging Division calls for significant costs cutting "from development to sales". Nikon will also focus on growth in emerging markets (most notably in China) by introducing new low cost products, and by launching a new marketing strategy.
In a bit of good news, Nikon intends to improve retention of existing customers, as they know many customers will undoubtedly jump ship to competitors.
Nikon stock is currently getting hammered at market open, down over 3% intraday in Tokyo.